An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk

Abstract

Background

Risk prediction models for cardiovascular death are important for providing advice on lifestyle and in decision-making regarding primary preventive drug treatment. The latest Swedish version of the Systematic COronary Risk Evaluation (SCORE 2015) has yet not been tested in the population.

Objective

The objective of this study was to estimate the prevalence of high and very high risk of fatal cardiovascular disease (CVD) of the current population according to 2015 SCORE Sweden and to evaluate the predictive accuracy of the 2003 Swedish version of SCORE (2003 SCORE Sweden) and 2015 SCORE Sweden in a population with declining CVD mortality.

Methods

We estimated the high and very high risk group for cardiovascular death for individuals 40–65 years of age in the 2014 Northern Sweden MONICA population survey excluding subjects with known diabetes or previous CVD (n = 813). Using the 1999 MONICA survey (n = 3347) followed up for 10 years for CVD mortality, we assessed the calibration of both 2003 and 2015 SCORE Sweden.

Results

In 2014 2.6% of the population was considered at high or very high risk for fatal CVD, 95% were men and 76% were in the age group 60–65 years. Including subjects with a single markedly elevated risk factor, known diabetes or CVD, 12% of the population was at high or very high risk. During 10 years of follow-up of the 1999 cohort, 34 CVD deaths (24 men and 10 women) occurred. The 2003 SCORE overestimated the risk of death from CVD (ratio predicted/observed 2.3, P < 0.001) whereas the 2015 SCORE slightly overestimated the number of deaths (predicted/observed 1.3, P = 0.12). The 2015 SCORE predicted more accurately than the 2003 SCORE the number of deaths in the different risk and age categories.

Conclusion

The 2015 SCORE Sweden more adequately than 2003 SCORE Sweden predicts the number of deaths. In 2014, the proportion of high-risk individuals is small in northern Sweden. The main use of 2015 SCORE Sweden would therefore be as an educational tool between the physician and people without diabetes or CVD in a consultation regarding cardiovascular risk.

Keywords

Cardiovascular disease cohort study mortality SCORE prediction

Get full access to this article

View all access options for this article.

References

Berg J, Björck L, Lappas G, et al. Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord 2014; 14: 9. doi: 10.1186/1471-2261-14-9.

Anderson

Odell

Wilson

, et al.. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–298.

Hippisley-Cox

Coupland

Vinogradova

, et al.. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335: 136–136.

Pyörälä

De Backer

Graham

, et al.. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.

De Backer

Ambrosioni

Borch-Johnsen

, et al.. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10: S1–S10.

Conroy

Pyorala

Fitzgerald

, et al.. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

Perk

De Backer

Gohlke

, et al.. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635–1701.

Pyörälä

. Cardiovascular risk prediction systems have to be adapted and updated to current national conditions. Eur J Cardiovasc Prev Rehabil 2006; 13: 674–675.

Getz

Sigurdsson

Hetlevik

, et al.. Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 2005; 331: 551–551.

10.

Holm

Olsen

Borglykke

, et al.. Estimating the proportion of Danes at high risk of fatal cardiovascular disease. Scand J Public Health 2011; 39: 571–576.

11.

Stenlund

Lönnberg

Jenkins

, et al.. Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population. Eur J Cardiovasc Prev Rehabil 2009; 16: 321–324.

12.

Marques-Vidal

Rodondi

Bochud

, et al.. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil 2008; 15: 402–408.

13.

De Bacquer

De Backer

. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol 2010; 143: 385–390.

14.

Hense

Koesters

Wellmann

, et al.. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany. Eur J Cardiovasc Prev Rehabil 2008; 15: 409–415.

15.

Läkemedelsverket (Swedish Medical Drug Agency). [To prevent atherosclerotic cardiovascular disease with drugs - recommendations for treatment.]. Information från Läkemedelsverket 2014; 25: 20–20. (in Swedish).

16.

Wilhelmsen

Wedel

Conroy

, et al.. Det svenska SCORE – diagrammet för kardiovaskulär risk. Läkartidningen 2004; 101: 1798–1801.

17.

Eriksson M, Forslund A, Jansson J, et al. Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population. The Northern Sweden MONICA study 1994 to 2014. Eur Heart J 2016; 37: 1985–92. doi: 10.1093/eurheartj/ehw052.

18.

Eriksson

Holmgren

Janlert

, et al.. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009. J Intern Med 2011; 269: 219–231.

19.

Lindman

Veierod

Pedersen

, et al.. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil 2007; 14: 501–507.

20.

Getz

Kirkengen

Hetlevik

, et al.. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study. Scand J Prim Health Care 2004; 22: 202–208.

21.

Petursson

Getz

Sigurdsson

, et al.. Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population. J Eval Clin Pract 2009; 15: 103–109.

22.

Hartz

Njolstad

Eggen

. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001. Eur Heart J 2005; 26: 2673–2680.

23.

Siontis

Tzoulaki

Siontis

, et al.. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 2012; 344: e3318–e3318.

24.

Björck

Rosengren

Bennett

, et al.. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30: 1046–1056.

25.

Björck

Capewell

O’Flaherty

, et al.. Decline in coronary mortality in Sweden between 1986 and 2002: comparing contributions from primary and secondary prevention. PLoS One 2015; 10: e0124769–e0124769.

26.

Petersson

Östgren

Brudin

, et al.. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2009; 16: 536–540.

27.

Wald

Simmonds

Morris

. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS One 2011; 6: e18742–e18742.

28.

Gaziano

Young

Fitzmaurice

, et al.. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008; 371: 923–931.

29.

Cooney

Dudina

D’Agostino

, et al.. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 2010; 122: 300–310.

30.

Cooney

Selmer

Lindman

, et al.. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol 2016; 23: 1093–1103.